Фармазолин

Quick links

Choose a section

Quick links to important sections

Advertisements

Фармазолин

Selected form

Advertisements
Advertisements

Method of action: Vasoconstrictor

Advertisements

Overview of Фармазолин

Quick Facts

Property Description
Active ingredient Xylometazoline Hydrochloride
Form Aqueous solution (Nasal drops or spray)
Pharmacological class alpha-Adrenomimetic / Nasal Decongestant
Common use Relief from nasal congestion (stuffy nose)
Origin Synthetic (Imidazoline derivative)

Фармазолин: Defining the Active Ingredient and Class

Фармазолин is the trade name for a medicine whose core component is the active ingredient Xylometazoline Hydrochloride (Ксилометазолина гидрохлорид). This substance is categorized as an alpha-Adrenomimetic, placing it within the pharmacological class of Nasal Decongestants (сосудосуживающие препараты). The compound is synthetic, chemically classified as an imidazoline derivative.

Xylometazoline is clinically recognized for its ability to swiftly alleviate mucosal swelling. This means the medication is designed to activate local receptors that physically tighten the blood vessels, leading to the rapid reduction of tissue volume. As a well-established decongestant, Фармазолин is typically distributed as an Over-the-Counter (OTC) product, making it readily accessible for common, temporary nasal discomfort.

Physical Form and General Purpose

Фармазолин is formulated as a sterile aqueous solution intended exclusively for intranasal administration, commonly distributed as nasal drops or a nasal spray. The primary objective of the medicine is to provide effective relief from the symptoms of a blocked or stuffy nose.

The local route of administration allows Xylometazoline, when delivered intranasally, to achieve significant concentration at the site of action. This focused delivery is central to its purpose: mitigating the tissue swelling (edema) and excessive blood flow (hyperemia) in the nasal lining, which are the physical conditions that obstruct normal nasal breathing.

How Фармазолин Delivers Relief (High-Level Mechanism)

The mechanism by which relief is achieved involves Фармазолин acting as a local-acting vasoconstrictor that triggers the immediate narrowing of the small blood vessels in the nasal lining. This physiological action decreases the volume of blood pooled within the nasal tissues, which leads directly to a physical reduction in the size of the swollen tissue. This characteristic shrinking action is the mechanism responsible for rapidly clearing the obstructed nasal airway and restoring airflow.

Advertisements

What side effects are possible with Фармазолин?

Official Adverse Reactions and Safety Profile

The safety profile of Фармазолин, containing Xylometazoline Hydrochloride, is documented in official regulatory sources according to the frequency and physiological system affected.

Frequency-Classified Adverse Reactions

The most Common adverse reactions are primarily localized effects at the application site, including nasal dryness, stinging or burning sensation in the nose and throat, and sneezing.

Uncommon reactions include hypersensitivity (allergic) reactions and, crucially, rebound congestion (rhinitis medicamentosa), which is associated with prolonged use. Rare effects are systemic and may include headache, nausea, palpitations, tachycardia (increased heart rate), and hypertension (elevated blood pressure).

System-Organ Class Examples of Documented Effects
Respiratory Disorders Nasal burning/stinging, dryness of mucous membranes, rebound congestion
Cardiac/Vascular Disorders Tachycardia, Palpitations, Hypertension (Rare)
Nervous System Disorders Headache, Dizziness, Insomnia

Safety Constraints and Duration-Related Risk

Serious adverse reactions are rare but are linked to high systemic absorption, potentially causing severe cardiovascular events or CNS depression, particularly following accidental ingestion or excessive use. This medicine is contraindicated in specific populations due to its sympathomimetic action, including individuals with narrow-angle glaucoma, severe hypertension, coronary artery disease, or hyperthyroidism.

Regulatory documentation explicitly restricts prolonged continuous use (typically beyond 3–7 consecutive days). This limitation is based on the documented risk that extended exposure may lead to the development of tolerance and the worsening condition known as rebound congestion.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The following information is derived from official government regulatory documents detailing the overdose profile of Xylometazoline, the active ingredient in Фармазолин. Accidental ingestion or excessive use, particularly of large quantities, requires immediate medical attention.

Documented Overdose Manifestations

Official regulatory information describes overdose symptoms as occurring in two phases:

  • Initial CNS Stimulation: May include nervousness, agitation, headache, and restlessness, particularly noted in children.
  • Subsequent CNS Depression: Can progress to more severe states such as lethargy, drowsiness, stupor, and potentially coma.
  • Cardiovascular Effects: Include initial hypertension (high blood pressure) followed by potentially life-threatening hypotension (low blood pressure) and a severely slowed heart rate (bradycardia).

Critical Risk Factors

Children are highly sensitive to Xylometazoline toxicity. The regulatory profile specifically highlights the risk of severe CNS depression and the possibility of apnea (cessation of breathing) in infants and neonates following accidental ingestion.

Required Emergency Actions

Official documents state that there is no specific antidote for Xylometazoline overdose. You must seek emergency medical care immediately. Call a Poison Center or doctor without delay upon accidental ingestion, particularly if a child is involved. Treatment provided by healthcare professionals is symptomatic and supportive, focused on managing cardiovascular and CNS effects.

Advertisements

Therapeutic Uses of Фармазолин

Фармазолин is intended for the temporary relief of nasal congestion and stuffiness associated with various common conditions. Its primary therapeutic action is to support comfortable breathing when the nasal passages are blocked. The medication is used to alleviate symptoms that arise from the common cold, hay fever, and other upper respiratory allergies. It also helps manage related discomforts like sinus congestion and pressure.

The benefit of using this medication is centered on promoting the passage of air through the nose, which may enhance overall patient comfort and support easier rest. It provides relief for a range of symptoms, including difficulty breathing through the nose and the general feeling of nasal blockage, which commonly occur with conditions like seasonal or perennial rhinitis.


Quick Fact: Relief for Nasal Congestion

Фармазолин supports the reduction of swelling in the nasal lining to temporarily ease a blocked nose.

Regulatory References

  1. NIH MedlinePlus guidance
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Фармазолин (Xylometazoline)?

Eligibility for using Фармазолин is determined by official regulatory criteria, primarily based on age, existing health conditions, and drug strength. Use is strictly limited to individuals within approved age ranges for each concentration, and is prohibited in several patient groups.

Eligibility and Contraindications

Classification Population/Condition
Approved Adults and adolescents ge 12 years (0.1% strength); Children 2 to 10 years (0.05% strength).
Contraindicated Children under 12 years (0.1% strength) or under 2 years (0.05% strength); Patients with narrow-angle glaucoma, rhinitis sicca, or atrophic rhinitis.

Conditional Use

Фармазолин must be used with caution by patients with specific systemic conditions, including hypertension, cardiovascular disease, diabetes mellitus, and hyperthyroidism. Use is also restricted for patients currently taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of cessation.

Pregnancy and Lactation Status

Use is not recommended during pregnancy, especially in the first trimester. Breastfeeding mothers should only use this medicine upon the advice of a healthcare professional.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Фармазолин (Xylometazoline) may interact with certain medications, primarily due to its potential to increase blood pressure and exert sympathomimetic effects. These interactions are based on official regulatory labeling.

Documented Pharmacodynamic Interactions

Interaction Type Interacting Medicines/Classes Official Restriction/Constraint
Contraindicated Monoamine Oxidase Inhibitors (MAOIs) Must not be used concurrently or within 14 days of stopping MAOI treatment.
Use with Caution Tricyclic and Tetracyclic Antidepressants Concomitant use is not recommended due to the risk of increased blood pressure.
Use with Caution Other Sympathomimetic Agents Risk of additive cardiovascular effects.
Potential Alteration Antihypertensives (e.g., Beta-Blockers) May alter the effectiveness of some blood pressure-lowering medicines.

Population and Timing Constraints

The label mandates a 14-day separation period between discontinuing MAOIs and initiating Xylometazoline use. Patients with Long QT syndrome should be aware of a potentially increased risk of serious ventricular arrhythmias. No specific interactions with food, alcohol, or herbal products are explicitly documented in core regulatory labeling.

Advertisements

Mechanism of Action

The mechanism of Phiармазолин (Xylometazoline) is defined by its direct influence on the autonomic nervous system to achieve localized physical changes within the nasal passages.

Targeting alpha-Adrenergic Receptors and Vascular Contraction

The active ingredient acts as a direct agonist that binds to the alpha-Adrenergic Receptors located on the smooth muscle of nasal blood vessels. This interaction initiates a signaling cascade characteristic of the sympathetic nervous system, compelling the vascular muscle to contract, a process known as vasoconstriction. This domain describes the molecule's specific action to modulate local vasodilation and restrict blood flow.

Physiological Shrinkage and Airway Adjustment

The direct molecular action results in a rapid and significant decrease in the diameter of blood vessels in the nasal submucosa. This reduction in local blood flow physically limits the accumulation of blood (hyperemia) and tissue fluid (edema). This mechanism of physiological shrinkage alters the configuration of the internal nasal passages, which results from a purely mechanical volume change.

Mechanistic Constraint (Tachyphylaxis and Desensitization)

The drug's mechanism is inherently limited by the biological response of the target receptors, a phenomenon termed tachyphylaxis. Continuous or repetitive activation causes the alpha-Adrenoceptors to become progressively less responsive to Xylometazoline, limiting the drug’s ability to maintain vasoconstriction over time. This constraint relates to the biological change where the vascular system does not sustain the initial level of smooth muscle tone following continuous exposure.

Advertisements

Dosage and Administration Information

How to Use Фармазолин

Administration of Xylometazoline, the active ingredient in Фармазолин, is limited to intranasal application as an aqueous solution, available in the forms of nasal drops or nasal spray.


Official Dosing and Frequency

Age Group Strength Standard Dosing (Per Nostril) Maximum Frequency
Adults & Adolescents (ge 12 years) 0.1% Solution 1 to 3 applications (drops or spray) Up to 3 times daily
Children (6 to 11 years) 0.05% Solution 1 to 2 applications (drops or spray) 1 to 2 times daily (under adult supervision)

Administration for children under 6 years is generally restricted. The maximum frequency must not be exceeded, and applications should be separated by several hours.


Course Duration and Procedural Requirements

The usage of Xylometazoline is defined by a short-term restriction, limited to a maximum of 5 to 7 consecutive days. This constraint is a fundamental rule of administration. Before applying the solution, the nasal passages should be thoroughly cleaned. For metered nasal sprays, the pump mechanism must be primed before the initial use to ensure the delivery of the correct dose. For hygienic purposes and to prevent the transmission of infection, the product should be used by only one person.

Advertisements

Recent Clinical Evidence

Фармазолин: Recent Clinical Evidence

Information regarding Xylometazoline is found primarily in formal clinical research, including randomized controlled trials (RCTs) and broader systematic reviews. These studies primarily was studied for temporary changes in symptoms associated with common, acute, and allergic conditions.


Evidence for Use in Acute Nasal Congestion

Research examined Xylometazoline in trials exploring changes in nasal congestion where subjects had symptoms associated with the common cold or acute rhinitis. These short-term RCTs were studied for how symptoms change over time when compared to an inactive placebo in adults over 18 years of age. Studies monitored both physical changes—such as objective measures of nasal air passage—and subjective patient-reported outcomes. Findings describe patterns observed in the studies related to measured changes in nasal air passage during the brief study period.

Research on Outcomes Beyond Nasal Airflow

Beyond the direct physical outcomes, research explored outcomes reflecting daily functioning and activity level. Applied in studies examining patient-reported experiences, this included monitoring factors such as perceived sleep quality and energy levels. Data show patterns related to how outcomes describing episodic changes were monitored in these functional axes, contributing to understanding symptom patterns in daily life.


Study Duration, Populations, and Gaps

The majority of studies relevant in trials assessing short-term symptom patterns are limited to a follow-up duration of seven consecutive days or less. Follow-up durations were limited to reflect the need to avoid a specific risk associated with prolonged use. Therefore, long-term effects are not fully established.

Evidence related to the use in children under 12 years of age is limited, and data for older adult populations remain insufficient. Furthermore, when was studied for allergic rhinitis, research often involves combination products, meaning the specific effect of Xylometazoline alone is not always isolated. The overall evidence quality ranges from high (for acute short-term studies) to moderate (for studies of quality of life or combination use).

Key Studies & References

  1. DrugBank: Xylometazoline (DB00898)
  2. Xylometazoline Nasal Spray/Drops (MedlinePlus Drug Information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Фармазолин (FAQ)


Q: Is Фармазолин the same as other nasal drops like Naphazoline or Xylometazoline?

Фармазолин is the trade name for a medicine containing the active ingredient Xylometazoline. Both Xylometazoline and medicines containing Naphazoline are classified in official sources as nasal decongestants called imidazoline derivatives. This means they belong to the same pharmacological class and have a similar way of working by causing blood vessels to constrict.


Q: How long does the effect of Фармазолин usually last?

According to official product information, the local vasoconstrictor effect of Xylometazoline is generally reported to last between 6 and 10 hours. This duration reflects the period during which the decongestant action provides relief from a stuffy nose.


Q: Can Фармазолин be used for allergies or just for colds?

Official information indicates that the medication is suitable for providing temporary relief from congestion associated with both the common cold and various forms of rhinitis, including acute rhinitis and allergic rhinitis (such as hay fever). The purpose is to address the nasal congestion symptom in these conditions.


Q: Can children of all ages use Фармазолин?

Regulatory guidance strictly specifies the appropriate age group for each concentration. The 0.05% strength is typically indicated for children aged 6 to 11 years, while the 0.1% strength is for adults and adolescents 12 years and older. Use in children younger than 6 years is generally restricted or contraindicated by official labeling.


Q: Can Фармазолин cause a dry nose or throat?

Yes, official regulatory documents list dryness of the nasal lining, or nasal dryness, as a common side effect of the medicine. Users may also experience a burning or stinging sensation that can affect both the nose and the throat area upon application.


Q: How does Фармазолин compare to saline nasal sprays?

Фармазолин (Xylometazoline) is a pharmacological nasal decongestant that actively shrinks swollen tissue by tightening blood vessels (vasoconstriction). In contrast, saline nasal sprays are non-pharmacological products. They are used primarily to moisten the nasal passages, thin mucus, and help clear the nasal passages physically.


Q: Why do some people experience palpitations after using Фармазолин?

Palpitations, which are noticeable changes in heart rhythm, are listed as a rare systemic side effect. This may occur because the active ingredient is a sympathomimetic agent. If absorbed systemically (into the body), it has the potential to activate alpha-adrenergic receptors in the cardiovascular system, which can affect heart rate and rhythm.


Q: What happens if I accidentally swallow some Фармазолин?

Accidental ingestion, especially by young children, may lead to serious systemic effects due to the rapid absorption of the active ingredient. Official warnings state that this can cause cardiovascular symptoms, such as changes in heart rate and blood pressure, or central nervous system depression. Immediate medical attention is required in cases of accidental ingestion.


Q: What should I do if I miss a dose of Фармазолин?

The standard instruction in regulatory patient information is that double doses should not be taken to compensate for a forgotten dose. Instead, it is advised to continue with the next scheduled application, ensuring doses are separated by the recommended time interval.


Q: Is it possible for Фармазолин to cause dizziness or headaches?

Dizziness and headache are listed in official regulatory documents as documented, though rare, adverse effects. If these rare effects occur, this information should be discussed with a healthcare professional.


Q: What happens if I use expired Фармазолин?

Regulatory guidelines require the medicine to be discarded after the expiration date printed on the label. This is because once expired, the product's potency and sterility can no longer be guaranteed, which affects both its safety and effectiveness.


Q: Can I use Фармазолин at night to help with sleep?

While the drug's decongestant action can help clear a blocked nose, which may aid sleep, official documentation notes that insomnia (difficulty sleeping) is a rare side effect. Guidance on the latest recommended time of daily use can be found in the product's instructions.


Q: Can I use Фармазолин if I have recently had nasal surgery?

The medicine is generally contraindicated (should not be used) following certain nasal procedures. This includes post-operative states such as after transsphenoidal hypophysectomy or any nasal or oral surgery where the dura mater (the covering of the brain) may have been exposed.


Q: Can Фармазолин be used to treat a stuffy nose from changes in air pressure?

The primary indication is for congestion associated with rhinitis and sinusitis. While the medication's vasoconstrictive effect reduces mucosal swelling, which may be associated with air pressure changes (barotrauma), using it for this specific purpose is not a main regulatory indication.


Q: Why do doctors prescribe Фармазолин for ear congestion sometimes?

Official therapeutic indications often include the relief of congestion of the nasopharyngeal mucosa that is associated with acute otitis media (middle ear inflammation). The decongestant action can help open the Eustachian tube, thereby aiding in the relief of associated ear congestion.


Q: Does alcohol consumption affect how Фармазолин works?

Core regulatory documentation typically does not contain specific interaction warnings for alcohol consumption and Xylometazoline. Due to potential interactions with other cold remedies, caution is generally indicated.


Q: Can I use Фармазолин with other cold remedies like lozenges or syrups?

Regulatory information indicates that caution is necessary when combining Фармазолин with other sympathomimetic agents, which are often found in other cold and flu remedies (e.g., certain oral decongestants). This combination carries a risk of additive cardiovascular effects, such as increased heart rate or blood pressure.


Q: Does Фармазолин have any known effects on driving or operating machinery?

When used correctly according to instructions, the medication is generally considered to have no influence on the ability to drive or operate machinery. Because of the possibility of rare systemic side effects like dizziness or headache, exercising caution is indicated.


Q: Is the active substance in Фармазолин derived from a natural source?

No, the active substance, Xylometazoline Hydrochloride, is a synthetic chemical compound. It belongs to the class of imidazoline derivatives, which are produced through chemical synthesis.


Q: Are there different concentrations of Фармазолин available?

Yes, regulatory documents confirm that the medicine is typically available in two different concentrations. These include a 0.05% strength for use in children and a 0.1% strength for use in adults and adolescents.


Q: Does using Фармазолин help prevent sinus infections?

The medication is indicated to relieve the symptoms of congestion associated with conditions such as sinusitis. While clearing nasal passages may help, its use as a preventive measure for infections is not a stated regulatory indication.


Q: Is it possible to develop a tolerance to the effects of Фармазолин?

Yes, official warnings state that repeated and excessive use of nasal decongestants can lead to tachyphylaxis, which means the drug becomes progressively less effective. This diminishing effectiveness is often referred to by users as developing a tolerance, and it frequently results in rebound congestion.


Q: What scientific studies support the use of Фармазолин for nasal congestion?

The use of Xylometazoline is supported by a history of clinical evidence, including short-term randomized controlled trials (RCTs). These studies have assessed its established vasoconstrictive and decongestant effects compared to placebo, leading to its current regulatory approval for relieving nasal congestion.

Advertisements

How should Фармазолин be stored and disposed of?

How to Store and Dispose of Фармазолин?

Storage of this medicine must comply with specific regulatory requirements to maintain product stability and safety. The product must be stored at controlled room temperature, typically below 25 C or 30 C, as indicated on the label, and it should be protected from freezing unless otherwise directed. To maintain its quality, the medicine must be stored in its original primary container and kept in the outer carton to shield it from light and moisture.

After any dilution or reconstitution, a strict in-use stability period must be followed, after which any remaining portion must be immediately discarded. All medicine must be kept out of the sight and reach of children and pets. Disposal of unused or expired medicine should prioritize official drug take-back programs. If a take-back option is unavailable, the medicine must be disposed of safely in the household trash (mixed with an unappealing substance like dirt or cat litter and sealed in a bag) to prevent accidental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Фармазолин found in:

A-Z Index: